A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous cell lung cancer (SqCLC) previously treated with platinum-based chemotherapy.

被引：1
|
作者：
Scagliotti, Giorgio V.
Govindan, Ramaswamy
Hurt, Karla
Chiang, Alan
机构：
[1] Univ Turin, Turin, Italy
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Eli Lilly, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.TPS9101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9101
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy
    Machiels, Jean-Pascal Henry
    Van Maanen, Aline
    Vandenbulcke, Jean-Marie
    Filleul, Bertrand
    Seront, Emmanuel
    Henry, Stephanie
    D'Hondt, Lionel
    Lonchay, Christophe
    Holbrechts, Stephane
    Boegner, Petra
    Brohee, Dany
    Dequanter, Didier
    Louviaux, Ingrid
    Sautois, Brieuc
    Whenham, Nicolas
    Berchem, Guy
    Vanderschueren, Brigitte
    Fontaine, Christel
    Schmitz, Sandra
    Gillain, Aline
    Schoonjans, Joelle
    Rottey, Sylvie
    ONCOLOGIST, 2016, 21 (12): : 1416 - +
  • [22] Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
    Nokihara, H.
    Lu, S.
    Mok, T. S. K.
    Nakagawa, K.
    Yamamoto, N.
    Shi, Y. K.
    Zhang, L.
    Soo, R. A.
    Yang, J. C.
    Sugawara, S.
    Nishio, M.
    Takahashi, T.
    Goto, K.
    Chang, J.
    Maemondo, M.
    Ichinose, Y.
    Cheng, Y.
    Lim, W. T.
    Morita, S.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2698 - 2706
  • [23] A randomized phase 3 study of abemaciclib versus erlotinib in previously treated patients with stage IV NSCLC with KRAS mutation: JUNIPER.
    Goldman, Jonathan Wade
    Mazieres, Julien
    Barlesi, Fabrice
    Koczywas, Marianna
    Dragnev, Konstantin H.
    Goksel, Tuncay
    Cortot, Alexis B.
    Girard, Nicolas
    Wesseler, Claas
    Bischoff, Helge
    Nadal, Ernest
    Park, Keunchil
    Lu, Shun
    Taus, Alvaro
    Cobo, Manuel
    Hurt, Karla
    Chiang, Alan
    Hossain, Anwar
    John, William J.
    Paz-Ares, Luis G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Outcomes of second-line chemotherapy in Japanese patients with small cell lung cancer previously treated with platinum-based chemotherapy
    Haruyasu, Murakami
    Naito, Tateaki
    Kaira, Kyoichi
    Tsuya, Asuka
    Nakamura, Yukiko
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S817 - S818
  • [25] Nivolumab combined docetaxel versus nivolumab in patients with previously treated nonsmall cell lung cancer: a phase 2 study
    Wang, Yang
    Hao, Qianyun
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Zhang, Jie
    Chen, Xiaoling
    Ma, Xiangjuan
    Tian, Guangming
    Han, Jindi
    Han, Sen
    Wu, Di
    Long, Jieran
    Zhang, Ziran
    Fang, Jian
    ANTI-CANCER DRUGS, 2024, 35 (05) : 412 - 417
  • [26] Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyA phase II trial
    Faruk Tas
    Cumhur Demir
    Hakan Camlica
    Zeki Ustuner
    Erkan Topuz
    Medical Oncology, 2004, 21 : 233 - 240
  • [27] A phase III study of docetaxel versus docetaxel plus gemcitabine in refractory non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy: Results of a Japan Clinical Oncology Group randomized trial (JCOG0104)
    Yoh, Kiyotaka
    Nishiwaki, Yutaka
    Takeda, Koji
    Negoro, Shunichi
    Tamura, Tomohide
    Kudoh, Shinzoh
    Fukuda, Haruhiko
    Saijo, Nagahiro
    ANNALS OF ONCOLOGY, 2004, 15 : 166 - 167
  • [28] Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) previously treated with platinum-based therapy
    Rottey, Sylvie
    Van Maanen, Aline
    Vandenbulcke, Jean-Marie
    Filleul, Bertrand
    Seront, Emmanuel
    Henry, Stefanie
    D'Hondt, Lionel A.
    Lonchay, Christophe
    Holbrechts, Stephane
    Boegner, Petra
    Brohee, Dany J.
    Dequanter, Didier
    Louviaux, Ingrid
    Sautois, Brieuc
    Whenham, Nicolas
    Berchem, Guy J.
    Vanderschueren, Brigitte
    Fontaine, Christel
    Schmitz, Sandra
    Machiels, Jean-Pascal H.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Pilot study of low-dose weekly versus standard dose three-weekly docetaxel in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy
    Dawood, S
    Navaratnam, S
    Trottier, H
    Mihalcioiu, C
    LUNG CANCER, 2005, 49 : S242 - S242
  • [30] A randomized open-label study of gefitinib versus docetaxel in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who have previously received platinum-based chemotherapy
    Lee, D.
    Kim, S.
    Park, K.
    Kim, J.
    Lee, J.
    Shin, S.
    Kang, J.
    Suh, C.
    Ahn, M.
    Ahn, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345